SOLVENTUM CORPORATION (SOLV) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $701.00M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value $1.53B; Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $701.00M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $701.00M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | $1.53B | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Reported amount: $1.53B |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 9.44B USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities · Commercial Paper |
| Amounts owed to suppliers | 701.00M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Contract with Customer, Liability, Current |
| Deferred revenue due within one year | 596.00M USD | Contract with Customer, Liability, Current |
| Deferred revenue due after one year | (m) | Contract with Customer, Liability, Current |
| Reported other obligations due within one year | 1.53B USD | Other Liabilities, Current |
| Reported other noncurrent obligations | 486.00M USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) | Contract with Customer, Liability, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- $1.53B
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Obligation categories | (m) |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $701.00M | (m) | $1.53B | (m) | $9.44B | (m) | $596.00M | (m) | $486.00M | (m) |
| 2026-03-31 | (m) | $699.00M | (m) | $1.19B | (m) | $9.13B | (m) | $613.00M | (m) | $478.00M | (m) |
| 2025-12-31 | (m) | $687.00M | (m) | $1.39B | (m) | $9.24B | $5.04B | $621.00M | (m) | $547.00M | (m) |
| 2025-09-30 | (m) | $669.00M | (m) | $1.23B | (m) | $8.99B | $5.14B | $576.00M | (m) | $437.00M | (m) |
| 2025-06-30 | (m) | $643.00M | (m) | $1.01B | (m) | $11.43B | $7.82B | $557.00M | (m) | $371.00M | (m) |
| 2025-03-31 | (m) | $604.00M | (m) | $891.00M | (m) | $11.27B | $7.91B | $558.00M | (m) | $279.00M | (m) |
| 2024-12-31 | (m) | $618.00M | (m) | $1.04B | (m) | $11.50B | $8.01B | $572.00M | (m) | $410.00M | (m) |
| 2024-09-30 | (m) | $560.00M | (m) | $1.03B | (m) | $11.55B | $8.11B | $563.00M | (m) | $305.00M | (m) |
| 2024-06-30 | (m) | $495.00M | (m) | $960.00M | (m) | $11.71B | $8.31B | $505.00M | (m) | $305.00M | (m) |
| 2024-03-31 | (m) | $587.00M | (m) | $701.00M | (m) | $10.86B | $8.30B | $566.00M | (m) | $171.00M | (m) |
| 2023-12-31 | (m) | $477.00M | (m) | $677.00M | (m) | $2.28B | (m) | $574.00M | (m) | $152.00M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |